Full Event Guide

cover

Unmissable insights include:

  • Examining the mechanisms underlying immune tolerance to drive antigen and epitope discovery with insights from the NIH, Vaccibody, and Imcyse
  • Leveraging immune biomarkers and explore immune tolerance in diabetes with Novo Nordisk, COUR Pharmaceuticals, and Diamyd Medical
  • Exploring the diversity of technologies and platforms for antigen delivery with Toleranzia, Allero Therapeutics, Idogen AB, and AnTolRx, Inc
  • Optimizing clinical durability and efficacy of antigen-specific immunotherapies with insights from WORG Pharmaceuticals, and Cellerys